NEW ZEALAND GAZETTE, No. 107

14 SEPTEMBER 2006

Diphenylpyraline; except when specified elsewhere in this
Schedule
Doxylamine; except when specified elsewhere in this
Schedule
Exenatide
Mepyramine; except when specified elsewhere in this
Schedule
Paracetamol; except when specified elsewhere in this
Schedule
Phenyltoloxamine
Promethazine; except when specified elsewhere in this
Schedule
Sitagliptin
Sorafenib
Sumatriptan; except when specified elsewhere in this
Schedule
Telbivudine
Thenyldiamine
Trimeprazine; except when specified elsewhere in this
Schedule
Triprolidine; except when specified elsewhere in this
Schedule
Varenicline

Schedule 2

Restricted Medicines

Azatadine; for oral use in adults and children over two years
of age

Brompheniramine; for oral use medicines for adults and
children over two years of age except when specified
elsewhere in this Schedule

Chlorpheniramine; for oral use in medicines for adults and
children over two years of age except when specified
elsewhere in this Schedule

Dexchlorpheniramine; for oral use in medicines for adults
and children over two years of age except when
specified elsewhere in this Schedule

Dimenhydrinate; for oral use in medicines for adults and
children over two years of age except when specified
elsewhere in this Schedule

Diphenhydramine; for oral use in medicines for adults and
children over two years of age except when specified
elsewhere in this Schedule

Diphenylpyraline; for oral use in medicines for adults and
children over two years of age except when specified
elsewhere in this Schedule

Doxylamine; for oral use in medicines for adults and
children over two years of age except when specified
elsewhere in this Schedule

Hydrocortisone and hydrocortisone acetate but no other
esters of hydrocortisone; for dermal use in medicines
containing 1% or less but more than 0.5% by weight
of hydrocortisone base with no other ingredient except
an antifungal and in a quantity of 30 grams or less or
30 millilitres or less per container; in rectal medicines
containing 1% or less but more than 0.5% by weight of
hydrocortisone base and in combination with a local
anaesthetic and in a quantity of 35 grams or less per
container or up to 12 suppositories per pack.

Ibuprofen; for oral use in tablets or capsules containing up
to 400 milligrams per dose form and in packs containing
not more than 50 dose units which have received the
consent of the Minister or the Director-General to their
distribution as restricted medicines and are sold in the
manufacturer’s original pack

Mepyramine; for oral use in adults and children over two
years of age

Promethazine; for oral use in adults and children over two
years of age except when specified elsewhere in this
Schedule

Sumatriptan; for oral use in medicines for the acute relief
of migraine attacks with or without aura in patients who
have a stable, well-established pattern of symptoms
when in tablets containing 50 milligrams or less per
tablet and when sold in a pack containing not more than
two tablets which has received the consent of the
Minister or the Director-General to its sale as a restricted
medicine

Trimeprazine; for oral use in adults and children over two
years of age when in solid dose form or in liquid form
containing 10 milligrams or less of trimeprazine per
5 millilitres

Triprolidine; for oral use in medicines for adults and
children over two years of age except when specified
elsewhere in this Schedule

Schedule 3

Pharmacy-only Medicines

Brompheniramine; for oral use in medicines for adults or
children over two years of age when combined in the
same container with one or more other therapeutically
active substances, either when in the bedtime dose of a
day-night pack containing brompheniramine or when at
least one of the other therapeutically active substances is
a sympathomimetic decongestant

Chlorpheniramine; for oral use in medicines for adults and
children over two years of age when combined in the
same container with one or more other therapeutically
active substances, either when in the bedtime dose of a
day-night pack containing chlorpheniramine or when at
least one of the other therapeutically active substances is
a sympathomimetic decongestant

Dexchlorpheniramine; for oral use in medicines for adults
and children over two years of age when combined in the
same container with one or more other therapeutically
active substances, either when in the bedtime dose of a
day-night pack containing dexchlorpheniramine or when
at least one of the other therapeutically active substances
is a sympathomimetic decongestant

Dimenhydrinate; for oral use in a sealed container of not
more than 10 tablets or capsules for the prevention or
treatment of motion sickness in adults and children over
two years of age except when sold at a transport terminal
or aboard a ship or plane

Diphenhydramine; for oral use in medicines for adults and
children over two years of age when combined in the
same container with one or more other therapeutically
active substances, either when in the bedtime dose of a
day-night pack containing diphenhydramine or when at
least one of the other therapeutically active substances
is a sympathomimetic decongestant; for oral use in a
sealed container of not more than 10 tablets or capsules
of diphenhydramine theoclate for the prevention or
treatment of motion sickness in adults and children over
two years of age except when sold at a transport terminal
or aboard a ship or plane

Diphenylpyraline; for oral use in medicines for adults and
children over two years of age when combined in the
same container with one or more other therapeutically
active substances, either when in the bedtime dose of a
day-night pack containing diphenylpyraline or when at
least one of the other therapeutically active substances is
a sympathomimetic decongestant

Doxylamine; for oral use in medicines for adults and
children over two years of age when combined in the
same container with one or more other therapeutically
active substances, either when in the bedtime dose of a